LabCorp
The current chairman, president and CEO of LabCorp, David King, in June announced his retirement from the position, after which he will become executive chairman of the board of directors.
The change will be effective on the first of November, at which time Adam Schechter, current lead independent director of LabCorp, will become president and CEO. His replacement will be chosen at a future date.
“Adam’s experience in global healthcare, demonstrated leadership capabilities and strategic contributions as a board member position him perfectly to succeed me as CEO. He knows our industry, our company, and our strategy, and is uniquely suited to continue to build on the power of our combined organization,” said King.
Before LabCorp, Schechter was a member of Merck’s executive committee and held several roles with the company since 1988.